Myocardial Protection by Nitrite: Evidence That This Reperfusion Therapeutic Will Not Be Lost in Translation☆
To access this article, please choose from the options below
☆ Dr Gladwin is listed as a coinventor on a National Institutes of Health government patent application for the use of NaNO2 for cardiovascular indications..
PII: S1050-1738(08)00099-6
doi:10.1016/j.tcm.2008.05.001
Published by Elsevier Inc.
